Interim report January–March 2021: Recovery and good profitability
First quarter: · Sales amounted to SEK 379 (334) million, corresponding to an increase of 14 percent in SEK. Sales increased by 20 percent in local currency. · Operating income before depreciation and amortisation (EBITDA) amounted to SEK 163 (116) million, corresponding to a margin of 43 (35) percent. Fluctuations in exchange rates negatively impacted EBITDA by SEK 10 million. · Net income amounted to SEK 119 (80) million, which gave earnings per share of SEK 1.09 (0.74). Gothenburg, April 22, 2021VITROLIFE AB (publ)Thomas Axelsson, CEO